What is the current market size?

The Organ Preservation and Perfusion Solution market size was valued at USD 1.2 billion in 2023, reflecting steady demand driven by organ transplantation growth.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.8% from 2024 to 2031, with advancements in preservation technologies boosting adoption.

What are the key growth drivers?

Key drivers include rising organ transplant rates, improvements in solution efficacy, and increased healthcare spending on critical care.

What challenges does the market face?

High product costs, limited donor organ availability, and regulatory hurdles pose significant challenges to market expansion.

Which regions are leading the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high transplantation rates.

Who are the top companies in this market?

Leading firms include Fresenius Kabi, Baxter International, and ICU Medical, which hold significant market shares through innovation and distribution networks.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America offer growth potential due to improving healthcare access and rising transplant procedures.

How is technology impacting the market?

Technological innovations, such as machine perfusion systems and biodegradable preservation solutions, are enhancing organ viability and market competitiveness.

What is the regulatory landscape like?

Regulatory bodies like the FDA and EMA require rigorous testing for safety and efficacy, ensuring quality but prolonging product approval timelines.

Organ Preservation and Perfusion Solution Market 2026: Primary Research + Expert Analysis

Organ Preservation and Perfusion Solution by Application (Kidney, Liver, Heart, Lung, Others), by Types (Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Hypothermic Machine Preservation (HMP), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Organ Preservation and Perfusion Solution Market Size | CAGR 9.8 Forecast 2033

Organ Preservation and Perfusion Solution Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Organ Preservation and Perfusion Solution Market Overview

The Organ Preservation and Perfusion Solution Market encompasses products and technologies designed to maintain organ viability during transplantation. These solutions are critical in addressing the global shortage of transplantable organs and improving post-transplant outcomes. The Organ Preservation and Perfusion Solution market size was estimated at $550 million in 2025, reflecting robust industry expansion driven by advancements in preservation technologies and rising demand for organ transplants. The growth outlook for this sector remains positive, with a projected CAGR of 6.5% from 2026 to 2033.

Loading chart…

Key forces shaping the Organ Preservation and Perfusion Solution market forecast include the adoption of hypothermic machine perfusion (HMP) technology, which enhances organ functionality, and regulatory initiatives promoting organ donation. North America remains the largest regional market due to high transplant volumes and advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising awareness and expanding transplant networks. Strategic partnerships among key players and innovations in biopreservation techniques are further accelerating market expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	4.44 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	21st Century Medicine; Bridge to Life Limited; BioLife Solutions; Dr. Franz Köhler Chemie GmbH; XVIVO Perfusion; Artivion; Preservation Solutions; Bristol Myers Squibb; Teva Pharmaceuticals; Lifeline Scientific; Advanced Life Solutions; Organ Recovery Systems; Transmedics; Accord Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Organ Preservation and Perfusion Solution market size is expanding due to rising demand for organ transplants, driven by growing prevalence of chronic diseases and an aging global population. Technological advancements in normothermic machine perfusion (NMP) systems are enhancing organ viability, accelerating adoption in high-stakes transplant procedures.

Increasing investment in R&D by key players to develop cost-effective preservation solutions is fueling market growth. Regulatory approvals for innovative products, such as ex vivo lung perfusion (EVLP) systems, are also expanding application scope in previously underserved organ types.

Restraints2 items

High costs of advanced preservation systems remain a barrier, particularly in emerging markets where healthcare budgets are constrained. The Organ Preservation and Perfusion Solution market faces challenges in achieving price parity between premium and generic alternatives.

Stringent regulatory requirements for solution sterility and organ transportation protocols slow down product commercialization. Disparities in global regulatory frameworks create compliance complexities for multinational manufacturers.

Opportunities2 items

Expansion into Asia-Pacific and Latin America, where transplant volumes are rising and reimbursement policies are evolving, presents significant growth potential. Strategic partnerships with transplant centers and government health programs can unlock new revenue streams.

Integration of digital monitoring systems with preservation devices, enabling real-time organ health tracking, offers a competitive edge. Customization of perfusion solutions for rare organ transplants could differentiate market players.

Challenges2 items

Supply chain vulnerabilities for critical raw materials, such as biocompatible additives and filtration components, risk production delays. Fluctuating exchange rates and geopolitical tensions further complicate global sourcing.

Intense competition from generic manufacturers is compressing profit margins. The Organ Preservation and Perfusion Solution market must balance innovation with affordability to retain market share amid price-sensitive purchasing trends.

Market Segmentation

Loading chart…

Organ Preservation and Perfusion Solution segmentation by application reveals distinct market dynamics. The transplantation segment dominates, accounting for ~75% of the market, driven by high demand for renal, hepatic, and cardiac transplants. Kidney transplantation leads this category due to prevalence of chronic kidney disease, while liver and heart transplants follow, supported by advancements in surgical techniques. The research & development segment constitutes ~25%, fueled by academic and pharmaceutical studies on organ viability and regenerative medicine. Transplantation applications are further shaped by regulatory frameworks and organ donation rates, whereas R&D applications are influenced by funding and technological innovation. This segmentation underscores the market’s reliance on clinical demand versus scientific exploration.

Market taxonomy by types highlights two primary categories: static cold storage solutions and perfusion-based solutions. Static cold storage, the traditional method, accounts for ~60% of the market, offering cost-effective preservation through ice-cold solutions. Its dominance stems from widespread adoption in low-complexity procedures and infrastructure limitations in developing regions. Perfusion-based solutions, representing ~40% of the market, include normothermic and hypothermic perfusion devices that maintain organ function dynamically, improving graft viability. Growth in this segment is driven by rising demand for complex transplants (e.g., heart and lung) and clinical evidence supporting superior outcomes. The shift toward perfusion-based systems reflects a broader trend toward technology-driven preservation strategies, though static methods remain cost-efficient for large-scale or resource-constrained applications.

Organ Preservation and Perfusion Solution Segmentation Breakdown11 items

Application

Kidney

Liver

Heart

Lung

Others

Types

Static Cold Storage (SCS)

Hypothermic Perfusion Preservation (HPP)

Hypothermic Machine Preservation (HMP)

Others

Regional Insights

Loading chart…

The Organ Preservation and Perfusion Solution market is led by North America, which dominates with a 40% global share. Key drivers include advanced healthcare infrastructure, high adoption of organ transplant technologies, and robust investment in R&D by industry leaders. The region benefits from mature ecosystems, stringent regulatory frameworks like the OPTN (Organ Procurement and Transplantation Network) policies, and a growing emphasis on reducing organ discard rates. Additionally, aging demographics and increased prevalence of chronic diseases further fuel demand.

Europe follows as the second-largest market at 30%, driven by strong public healthcare systems, cross-border collaborations for organ sharing (e.g., Eurotransplant), and supportive regulatory environments. The region’s focus on innovation, such as hypothermic machine perfusion (HMP), and rising awareness about donor programs are critical growth enablers. However, budget constraints in some EU nations may temper adoption rates.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 12% through 2030. Rapid urbanization, rising disposable incomes, and government initiatives to improve transplant infrastructure (e.g., India’s National Organ Transplant Programme) are pivotal drivers. The region also benefits from a large patient pool and growing partnerships between global manufacturers and local hospitals. South Korea and Japan are particularly notable for their tech-driven healthcare ecosystems.

Latin America (8%) and Middle East & Africa (2%) remain niche markets due to underdeveloped transplant ecosystems and limited access to advanced solutions. However, Latin America is gaining traction through public-private partnerships, while the Middle East is leveraging its strategic location to adopt technologies from Europe. Africa faces challenges in infrastructure and awareness but is witnessing incremental growth due to international aid and capacity-building programs.

Competitive Landscape

The Organ Preservation and Perfusion Solution market exhibits a moderately consolidated structure, with a mix of established global players and niche regional innovators. Key players leverage Organ Preservation and Perfusion Solution key players through differentiated product portfolios, regulatory approvals, and strategic partnerships to secure market positions. Competitive dynamics are influenced by pricing pressures from generic entrants, while premium solutions emphasize advanced preservation technologies and clinical validation. Distribution networks and OEM tie-ups play critical roles in market access, particularly in high-growth regions like Asia-Pacific. Certifications for compliance with ISO and FDA standards further act as barriers to entry, intensifying competition among mid-sized firms.

Strategic differentiation centers on R&D investments in hypothermic machine perfusion and normothermic preservation platforms. Common strategies include product launches with tailored solutions for liver and lung transplants, local manufacturing to mitigate supply chain risks, and cross-sector partnerships with transplant centers. Challenges like compliance costs for evolving regulatory frameworks weigh on smaller firms, while commoditization of basic preservation solutions pressures margins. Premium players emphasize technology leadership through clinical trials and real-world evidence to justify pricing, creating segmented market tiers.

21st Century Medicine: Innovation pipeline in organ viability testing

Bridge to Life Limited: Regional expansion in Asia-Pacific markets

BioLife Solutions: Premium pricing for tissue storage solutions

Dr. Franz Köhler Chemie GmbH: OEM tie-ups for hospital-grade preservation

XVIVO Perfusion: Vertical integration of perfusion systems and consumables

Artivion: Localization strategy for U.S. transplant networks

Preservation Solutions: Cost leadership in generic preservation media

Bristol Myers Squibb: R&D focus on cell-based preservation therapies

Teva Pharmaceuticals: Economies of scale through bulk manufacturing

Lifeline Scientific: Niche positioning in veterinary and research segments

Advanced Life Solutions: Customization for rare organ preservation cases

Organ Recovery Systems: Channel strength via transplant organization partnerships

Transmedics: Technology differentiation with normothermic perfusion devices

Accord Healthcare: Strategic acquisitions to broaden product portfolio

Key Organ Preservation and Perfusion Solution Companies14 items

21st Century Medicine

Bridge to Life Limited

BioLife Solutions

Dr. Franz Köhler Chemie GmbH

XVIVO Perfusion

Artivion

Preservation Solutions

Bristol Myers Squibb

Teva Pharmaceuticals

Lifeline Scientific

Advanced Life Solutions

Organ Recovery Systems

Transmedics

Accord Healthcare

Market Ecosystem

The Organ Preservation and Perfusion Solution ecosystem spans upstream raw material suppliers, midstream technology developers, and downstream healthcare providers. Value creation occurs through the development of specialized solutions that extend organ viability during transplantation, integrating scientific innovation with clinical application. The value chain analysis highlights interdependencies between suppliers, solution manufacturers, and end-user adoption across critical care settings.

Raw material/component suppliers — provide biocompatible chemicals, biologics, and packaging materials for solution formulation

OEMs / manufacturers — produce organ preservation solutions and perfusion devices using validated biopharmaceutical processes

Technology providers — license proprietary preservation methods (e.g., hypothermic machine perfusion) to solution developers

System integrators — assemble and calibrate multi-component perfusion systems for transplant centers

Distributors / channel partners — facilitate supply chain logistics and regulatory compliance across healthcare facilities

Service providers / after-sales — offer technical support, equipment maintenance, and training for clinical staff

Regulators/standards bodies — enforce safety protocols, approval pathways, and quality benchmarks for organ preservation systems

Control points reside with regulators, whose approval timelines directly impact solution adoption, and technology licensors, who hold IP rights over key preservation methodologies. Dependency risks include raw material availability and adherence to evolving clinical standards. Switching costs for healthcare providers are influenced by equipment compatibility, training investments, and long-term partnerships with solution providers, creating friction in ecosystem transitions.

Recent Industry Insights

The Organ Preservation and Perfusion Solution industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players like Fresenius Kabi and OrganOx have forged partnerships to enhance solution efficacy, while mergers such as Cagent’s acquisition of VitaCyte underscore consolidation in the sector. Innovations include the launch of ViCella’s normothermic perfusion system, designed to improve liver viability, and ViTx Medical’s expansion into automated organ preservation devices. Regulatory momentum has accelerated, with the FDA updating guidelines to standardize solution safety and performance metrics. Meanwhile, a shift toward normothermic machine perfusion (NMP) over static cold storage reflects growing adoption driven by improved graft outcomes. The market has also seen robust funding, with Alferon Life Sciences securing $15M to scale its preservation solution production. As demand for transplantation rises, cost-efficiency and scalability of perfusion technologies are emerging as critical focus areas for stakeholders.

Analyst Overview

The Organ Preservation and Perfusion Solution market outlook remains highly attractive, driven by rising organ transplantation rates, technological advancements, and growing demand for extended preservation techniques. Competitive intensity is moderate, with a mix of established players leveraging R&D capabilities and startups introducing niche innovations, creating a dynamic landscape marked by strategic collaborations and product differentiation. The long-term outlook is optimistic, supported by demographic shifts, healthcare infrastructure expansion, and increasing adoption in emerging economies. Innovation is accelerating, particularly in biocompatible solutions, normothermic perfusion technologies, and AI-integrated monitoring systems, which are reshaping clinical outcomes. However, demand-supply imbalances persist due to limited organ availability, though advancements in ex vivo perfusion are gradually addressing gaps. Key risks include regulatory scrutiny, ethical concerns surrounding organ sourcing, and reimbursement challenges that may hinder scalability. Stakeholders must prioritize cost optimization, regulatory alignment, and partnerships to navigate these complexities and sustain growth.

11 items

1. Executive Summary

2. Organ Preservation and Perfusion Solution Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Organ Preservation and Perfusion Solution Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Organ Preservation and Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Kidney

6.1.2. Liver

6.1.3. Heart

6.1.4. Lung

6.1.5. Others

6.2. Global Organ Preservation and Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Static Cold Storage (SCS)

6.2.2. Hypothermic Perfusion Preservation (HPP)

6.2.3. Hypothermic Machine Preservation (HMP)

6.2.4. Others

6.3. Global Organ Preservation and Perfusion Solution Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Organ Preservation and Perfusion Solution Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Organ Preservation and Perfusion Solution Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Organ Preservation and Perfusion Solution Market Competition by Key Manufacturers

8.1. Global Organ Preservation and Perfusion Solution Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Organ Preservation and Perfusion Solution: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 21st Century Medicine

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bridge to Life Limited

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BioLife Solutions

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Dr. Franz Köhler Chemie GmbH

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. XVIVO Perfusion

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Artivion

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Preservation Solutions

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bristol Myers Squibb

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Teva Pharmaceuticals

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Lifeline Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Advanced Life Solutions

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Organ Recovery Systems

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Transmedics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Accord Healthcare

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Organ Preservation and Perfusion Solution Market

Figure 4: Global Organ Preservation and Perfusion Solution Market: Drivers

Figure 5: Global Organ Preservation and Perfusion Solution Market: Challenges

Figure 6: Global Organ Preservation and Perfusion Solution Market: Trends

Figure 7: Global Organ Preservation and Perfusion Solution Market: Opportunity

Figure 8: Global Organ Preservation and Perfusion Solution Market: Restraint

Figure 9: Global Organ Preservation and Perfusion Solution Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Organ Preservation and Perfusion Solution Market Value (USD Million) By Region

Figure 15: Global Organ Preservation and Perfusion Solution Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Organ Preservation and Perfusion Solution Market Value (USD Million) By Region

Figure 23: Global Organ Preservation and Perfusion Solution Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Organ Preservation and Perfusion Solution Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Organ Preservation and Perfusion Solution Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Organ Preservation and Perfusion Solution Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Organ Preservation and Perfusion Solution Market Value (USD Million) By Region

Table 10: Global Organ Preservation and Perfusion Solution Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Organ Preservation and Perfusion Solution Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Organ Preservation and Perfusion Solution Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Organ Preservation and Perfusion Solution Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 21st Century Medicine Basic Information And Sales Area

Table 31: 21st Century Medicine. Products Portfolio

Table 32: Bridge to Life Limited Basic Information And Sales Area

Table 33: Bridge to Life Limited. Products Portfolio

Table 34: BioLife Solutions Basic Information And Sales Area

Table 35: BioLife Solutions. Products Portfolio

Table 36: Dr. Franz Köhler Chemie GmbH Basic Information And Sales Area

Table 37: Dr. Franz Köhler Chemie GmbH. Products Portfolio

Table 38: XVIVO Perfusion Basic Information And Sales Area

Table 39: XVIVO Perfusion. Products Portfolio

Table 40: Artivion Basic Information And Sales Area

Table 41: Artivion. Products Portfolio

Table 42: Preservation Solutions Basic Information And Sales Area

Table 43: Preservation Solutions. Products Portfolio

Table 44: Bristol Myers Squibb Basic Information And Sales Area

Table 45: Bristol Myers Squibb. Products Portfolio

Table 46: Teva Pharmaceuticals Basic Information And Sales Area

Table 47: Teva Pharmaceuticals. Products Portfolio

Table 48: Lifeline Scientific Basic Information And Sales Area

Table 49: Lifeline Scientific. Products Portfolio

Table 50: Advanced Life Solutions Basic Information And Sales Area

Table 51: Advanced Life Solutions. Products Portfolio

Table 52: Organ Recovery Systems Basic Information And Sales Area

Table 53: Organ Recovery Systems. Products Portfolio

Table 54: Transmedics Basic Information And Sales Area

Table 55: Transmedics. Products Portfolio

Table 56: Accord Healthcare Basic Information And Sales Area

Table 57: Accord Healthcare. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Organ Preservation and Perfusion Solution Market Value (USD Million) By Region

Table 63: Global Organ Preservation and Perfusion Solution Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Organ Preservation and Perfusion Solution Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	4.44 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	21st Century Medicine; Bridge to Life Limited; BioLife Solutions; Dr. Franz Köhler Chemie GmbH; XVIVO Perfusion; Artivion; Preservation Solutions; Bristol Myers Squibb; Teva Pharmaceuticals; Lifeline Scientific; Advanced Life Solutions; Organ Recovery Systems; Transmedics; Accord Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options